BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diago-Navarro E, Motley MP, Ruiz-Peréz G, Yu W, Austin J, Seco BMS, Xiao G, Chikhalya A, Seeberger PH, Fries BC. Novel, Broadly Reactive Anticapsular Antibodies against Carbapenem-Resistant Klebsiella pneumoniae Protect from Infection. mBio 2018;9:e00091-18. [PMID: 29615497 DOI: 10.1128/mBio.00091-18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Patro LPP, Rathinavelan T. Targeting the Sugary Armor of Klebsiella Species. Front Cell Infect Microbiol 2019;9:367. [PMID: 31781512 DOI: 10.3389/fcimb.2019.00367] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 Ramos PIP, Fernández Do Porto D, Lanzarotti E, Sosa EJ, Burguener G, Pardo AM, Klein CC, Sagot MF, de Vasconcelos ATR, Gales AC, Marti M, Turjanski AG, Nicolás MF. An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets. Sci Rep 2018;8:10755. [PMID: 30018343 DOI: 10.1038/s41598-018-28916-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
3 Bengoechea JA, Sa Pessoa J. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev 2019;43:123-44. [PMID: 30452654 DOI: 10.1093/femsre/fuy043] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 35.0] [Reference Citation Analysis]
4 Heesterbeek DAC, Angelier ML, Harrison RA, Rooijakkers SHM. Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications. J Innate Immun 2018;10:455-64. [PMID: 30149378 DOI: 10.1159/000491439] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
5 Rodrigues C, Sousa C, Lopes JA, Novais Â, Peixe L. A Front Line on Klebsiella pneumoniae Capsular Polysaccharide Knowledge: Fourier Transform Infrared Spectroscopy as an Accurate and Fast Typing Tool. mSystems 2020;5:e00386-19. [PMID: 32209717 DOI: 10.1128/mSystems.00386-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
6 Dorman MJ, Feltwell T, Goulding DA, Parkhill J, Short FL. The Capsule Regulatory Network of Klebsiella pneumoniae Defined by density-TraDISort. mBio 2018;9:e01863-18. [PMID: 30459193 DOI: 10.1128/mBio.01863-18] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 10.5] [Reference Citation Analysis]
7 Short FL, Di Sario G, Reichmann NT, Kleanthous C, Parkhill J, Taylor PW. Genomic Profiling Reveals Distinct Routes To Complement Resistance in Klebsiella pneumoniae. Infect Immun 2020;88:e00043-20. [PMID: 32513855 DOI: 10.1128/IAI.00043-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
8 Bruchmann S, Feltwell T, Parkhill J, Short FL. Identifying virulence determinants of multidrug-resistant Klebsiella pneumoniae in Galleria mellonella. Pathog Dis 2021;79:ftab009. [PMID: 33512418 DOI: 10.1093/femspd/ftab009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Shang Z, Chan SY, Song Q, Li P, Huang W. The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance. Research (Wash D C) 2020;2020:2016201. [PMID: 33083786 DOI: 10.34133/2020/2016201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Adamo R, Margarit I. Fighting Antibiotic-Resistant Klebsiella pneumoniae with "Sweet" Immune Targets. mBio 2018;9:e00874-18. [PMID: 29764953 DOI: 10.1128/mBio.00874-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
11 Kalfopoulou E, Huebner J. Advances and Prospects in Vaccine Development against Enterococci. Cells 2020;9:E2397. [PMID: 33147722 DOI: 10.3390/cells9112397] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Brennan-Krohn T, Manetsch R, O'Doherty GA, Kirby JE. New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae. Transl Res 2020;220:14-32. [PMID: 32201344 DOI: 10.1016/j.trsl.2020.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Kobayashi SD, DeLeo FR. Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae. Future Microbiol 2018;13:1343-6. [PMID: 30256152 DOI: 10.2217/fmb-2018-0189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Iskandar K, Murugaiyan J, Hammoudi Halat D, Hage SE, Chibabhai V, Adukkadukkam S, Roques C, Molinier L, Salameh P, Van Dongen M. Antibiotic Discovery and Resistance: The Chase and the Race. Antibiotics 2022;11:182. [DOI: 10.3390/antibiotics11020182] [Reference Citation Analysis]
15 Kalfopoulou E, Laverde D, Miklic K, Romero-Saavedra F, Malic S, Carboni F, Adamo R, Lenac Rovis T, Jonjic S, Huebner J. Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci. Infect Immun 2019;87:e00276-19. [PMID: 31285252 DOI: 10.1128/IAI.00276-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Guerra MES, Destro G, Vieira B, Lima AS, Ferraz LFC, Hakansson AP, Darrieux M, Converso TR. Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis. Front Cell Infect Microbiol 2022;12:877995. [DOI: 10.3389/fcimb.2022.877995] [Reference Citation Analysis]
17 Malachowa N, Kobayashi SD, Porter AR, Freedman B, Hanley PW, Lovaglio J, Saturday GA, Gardner DJ, Scott DP, Griffin A, Cordova K, Long D, Rosenke R, Sturdevant DE, Bruno D, Martens C, Kreiswirth BN, DeLeo FR. Vaccine Protection against Multidrug-Resistant Klebsiella pneumoniae in a Nonhuman Primate Model of Severe Lower Respiratory Tract Infection. mBio 2019;10:e02994-19. [PMID: 31848292 DOI: 10.1128/mBio.02994-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
18 Tarín-Pelló A, Suay-García B, Pérez-Gracia MT. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Expert Rev Anti Infect Ther 2022. [PMID: 35576494 DOI: 10.1080/14787210.2022.2078308] [Reference Citation Analysis]
19 Eichenberger EM, Thaden JT. Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria. Antibiotics (Basel) 2019;8:E37. [PMID: 30959901 DOI: 10.3390/antibiotics8020037] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 20.3] [Reference Citation Analysis]
20 Mukherjee S, Mitra S, Dutta S, Basu S. Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae. Front Med (Lausanne) 2021;8:634349. [PMID: 34179032 DOI: 10.3389/fmed.2021.634349] [Reference Citation Analysis]
21 Motley MP, Diago-Navarro E, Banerjee K, Inzerillo S, Fries BC. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae. mBio 2020;11:e02059-20. [PMID: 32900809 DOI: 10.1128/mBio.02059-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Berry SK, Rust S, Caceres C, Irving L, Bartholdson Scott J, Tabor DE, Dougan G, Christie G, Warrener P, Minter R, Grant AJ. Phenotypic whole-cell screening identifies a protective carbohydrate epitope on Klebsiella pneumoniae. MAbs 2022;14:2006123. [PMID: 34923908 DOI: 10.1080/19420862.2021.2006123] [Reference Citation Analysis]
23 Choi M, Tennant SM, Simon R, Cross AS. Progress towards the development of Klebsiella vaccines. Expert Rev Vaccines 2019;18:681-91. [PMID: 31250679 DOI: 10.1080/14760584.2019.1635460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
24 Campanero-Rhodes MA, Palma AS, Menéndez M, Solís D. Microarray Strategies for Exploring Bacterial Surface Glycans and Their Interactions With Glycan-Binding Proteins. Front Microbiol 2019;10:2909. [PMID: 32010066 DOI: 10.3389/fmicb.2019.02909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
25 Motley MP, Banerjee K, Fries BC. Monoclonal antibody-based therapies for bacterial infections. Curr Opin Infect Dis 2019;32:210-6. [PMID: 30950853 DOI: 10.1097/QCO.0000000000000539] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
26 Opoku-Temeng C, Kobayashi SD, DeLeo FR. Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines. Comput Struct Biotechnol J 2019;17:1360-6. [PMID: 31762959 DOI: 10.1016/j.csbj.2019.09.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]